Sign up now for the virtual SOSV Climate Tech Summit (Oct. 25-26)

LizarBio Therapeutics

Curing incurable diseases using cells

Team

Marcos Valadares

CEO

Diogo Biagi

Co-founder & Principal Investigator

Company details

LizarBio is developing the first end-to-end platform to cultivate and differentiate pluripotent stem cells at industrial scale. The key is in their proprietary negligible cost media and suspension based culture system that results in up to 100X reduction in cost unlocking huge therapeutic potential.

Get In Touch with LizarBio Therapeutics

Please tell us a little bit about yourself and why you'd like to get connected. LizarBio Therapeutics + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.